Solitary lung metastasis from gestational choriocarcinoma resected six years after hydatidiform mole: A case report  by Iijima, Yoshihito et al.
S
s
Y
I
a
b
c
a
A
R
R
2
A
A
K
G
H
L
V
1
t
t
a
m
4
i
9
n
i
7
a
(
i
h
h
2
cCASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 28 (2016) 231–233
Contents lists available at ScienceDirect
International  Journal  of  Surgery  Case  Reports
journa l h omepage: www.caserepor ts .com
olitary  lung  metastasis  from  gestational  choriocarcinoma  resected
ix  years  after  hydatidiform  mole:  A  case  report
oshihito  Iijima  (MD,  PhD)a,∗, Hirohiko  Akiyamaa,  Yuki  Nakajimaa, Hiroyasu  Kinoshitaa,
wao  Mikamib,  Hidetaka  Uramotoa,c, Tomomi  Hirataa
Division of Thoracic Surgery, Saitama Cancer Center, Japan
Division of Thoracic Surgery, Ishikiriseiki Hospital, Japan
Division of Thoracic Surgery, Kanazawa Medical University, Japan
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 1 August 2016
eceived in revised form
8 September 2016
ccepted 28 September 2016
vailable online 30 September 2016
eywords:
estational choriocarcinoma
ydatidiform mole
ung metastasis
ideo-assisted thoracic surgery
a  b  s  t  r  a  c  t
INTRODUCTION:  Recently,  the  opportunity  to encounter  lung  metastasis  from  choriocarcinoma  has
become  very  rare  for thoracic  surgeons,  since  chemotherapy  works  very  well  and  the  operative  indications
for  lung  metastasis  are  limited.
PRESENTATION  OF  CASE:  A 45-year-old  woman  with  a past history  of  hydatidiform  mole  six years  previ-
ously  was  found  to  have  a nodulous  chest  shadow  in the right  middle  lung  ﬁeld  on  a  chest  radiography.
She  was also  suspected  of  having  an ovarian  tumor  and  underwent  a total  abdominal  hysterectomy  and
bilateral salpingo-oophorectomy.  No  malignancy  was  detected  in the  ovaries  or uterus.  A thoracoscopic
partial  pulmonary  resection  was  then  performed  for  the  right  lower  lung  nodule.  The  pathological  diag-
nosis was  choriocarcinoma.  Her  preoperative  serum  beta-human  chorionic  gonadotropin  value  was  high
(482.8  mIU/mL).  Thus,  she  was  diagnosed  as  having  a pulmonary  metastasis  from  gestational  choriocar-
cinoma  arising  six  years  after  a complete  hydatidiform  mole.
DISCUSSION:  The  possibility  of  choriocarcinoma  arising  as  a solitary  lung  tumor  should  be considered
regardless  of the  interval  from  the  preceding  molar  pregnancy.  The  patient’s  medical  history  and  high
concentration  of  -hCG  in preoperative  residual  serum  were  helpful  in arriving  at  a  diagnosis  of  metastatic
gestational  CCA.
CONCLUSION: We  presented  pulmonary  metastasectomy  for  very  unique  and rare  metastatic  choriocar-
cinoma  arising  six  years  after  hydatidiform  mole.
©  2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Gestational choriocarcinoma (CCA) is the most aggressive
rophoblastic disease, and 50% of gestational CCA arise from hyda-
idiform mole (HM) during a prior pregnancy [1]. HM occurs in
bout 1 in 1000 pregnancies in Western countries and is somewhat
ore frequent in Asian countries [2]. CCA affects approximately 1 in
0,000 pregnancies and 1 in 40 HMs  in Western countries, whereas
n Southeast Asia and Japan the gestational CCA rates are higher at
.2 and 3.3 per 40,000 pregnancies [3]. The incidence of molar preg-
ancy has declined worldwide [4], with a resulting sharp decrease
n the incidence of gestational CCA [5]. Moreover, because of the
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high cure rate of gestational trophoblastic neoplasia (GTN) using
chemotherapy, the indication for surgical therapy for lung metas-
tasis is limited. Here, we  report a rare case of a lung metastasis from
gestational CCA arising six years after a complete HM.
2. Presentation of case
A 45-year-old woman who complained of irregular vaginal
bleeding was  suspected of having an ovarian tumor. She had a
past history of HM.  A nodulous chest shadow in the right mid-
dle lung ﬁeld had also been pointed out on a chest radiography
performed during a health examination at about the same time.
The right lung nodule could not be diagnosed by transbronchial
biopsy, and she was  referred to the Department of Gynecology
at our hospital. A total abdominal hysterectomy and bilateral
salpingo-oophorectomy were performed. A benign ovarian cyst
was diagnosed, and no malignancies in the ovaries or uterus were
found upon histopathological examination. She was  then referred
to our department for the diagnosis of the lung nodule. She had
no respiratory symptoms, and her physical examination showed
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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×ig. 1. Radiological ﬁndings. A CT scan shows a well-circumscribed nodule in S6 of
he right lung.
o abnormalities. Her laboratory data including tumor marker lev-
ls such as carcinoembryonic antigen, squamous cell carcinoma
ntigen, carbohydrate antigen (CA) 19-9, and CA 125 were within
he normal ranges. A computed tomography (CT) scan showed
 well-circumscribed nodule in segment 6 (S6) of the right lung
Fig. 1). Whole body 2-deoxy-2-[18F]-ﬂuorodeoxyglucose-positron
mission tomography (FDG-PET)/CT imaging showed a maximal
tandardized uptake value of 7.39 during the early phase to 9.57
uring the late phase only in the S6 nodule. A thoracoscopic par-
ial resection of the right S6 nodule was scheduled and performed
 weeks after the initial gynecologic surgery. Macroscopically, a
hite to reddish brown-colored, well-deﬁned tumor was found
ithin the resected specimen. A frozen section analysis revealed
 tumor that was  suspected to be a squamous cell carcinoma with
igniﬁcant keratinization, but it was very rare histology for a pri-
ary lung cancer. A metastatic tumor was thought to be a strong
ig. 2. Microscopic ﬁndings. (A) The tumor was  highly hemorrhagic and necrotic. H.E. st
hoblasts arranged in nests without a villus structure is visible. H.E. stain, ×20. (C) Tu
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possibility. The histopathological ﬁndings showed that the tumor
was highly hemorrhagic and necrotic and consisted of an intimate
admixture of atypical cytotrophoblasts and syncytiotrophoblasts
arranged in nests without a villus structure (Fig. 2A and B). The
immunohistological ﬁndings indicated that the tumor cells were
strongly positive for human chorionic gonadotropin (hCG) (Fig. 2C)
and positive for cytokeratin (CK) 7, but were negative for thy-
roid transcription factor-1, alpha fetoprotein, and CK 20. Other
organs that could have been potential primary sites of the sus-
pected malignancy could not be identiﬁed using CT and FDG-PET/CT
examinations. However, she had a past history of dilation and curet-
tage for a complete HM at the age of 39 years. Her preoperative
serum beta-human chorionic gonadotropin (-hCG) value was  high
at 482.8 mIU/mL and decreased to 23.1 mIU/mL on postoperative
day 10, and it had returned to within the normal range at one month
after the lung surgery. Thus, the patient was  diagnosed as having a
pulmonary metastasis from a gestational CCA arising six years after
a complete HM.  She underwent three cycles of chemotherapy with
methotrexate postoperatively. She was followed for 7 years and 3
months and showed no signs of recurrence.
3. Discussion
Gestational CCA is a type of GTN. Gestational CCA is deﬁned
as a malignant neoplasm composed of large sheets of biphasic,
markedly atypical trophoblasts without chorionic villi [6]. GTN is
the unique tumor that arises from gestational rather than mater-
nal tissue, and also it is highly curable in most patients with
chemotherapy even when the disease has metastasized. Recently,
the opportunity to encounter lung metastases of choriocarcinoma
has become very rare for thoracic surgeons, because of the excellent
outcome of chemotherapy, and the operative indications for lung
metastasis are limited. The International Federation of Gynecology
and Obstetrics (FIGO) deﬁned criteria for the diagnosis of GTN, and
also adopted a combined anatomic staging and the modiﬁed World
ain, ×10. (B) An intimate admixture of atypical cytotrophoblasts and syncytiotro-
mor cells were strongly positive for hCG. Immunohistochemistry against -hCG,
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ealth Organization (WHO) prognostic scoring system for GTN in
002 [7,8]. Treatment is based on classiﬁcation into risk groups
eﬁned by the stage and scoring system. Single-agent chemother-
py, usually methotrexate or actinomycin D, was  performed for
he patients with non-metastatic GTN (FIGO stage I) and low-risk
etastatic GTN (FIGO stage II–III, modiﬁed WHO  score < 7). Patients
ith high-risk metastatic GTN (FIGO stage IV or stage II–III of mod-
ﬁed WHO  score ≥7), are treated with multi-agent chemotherapy
ith or without adjuvant radiation or surgery [8]. The overall cure
ate with treatment is currently over 90%.
Gestational CCA frequently undergoes distant hematogenous
etastasis to various organs. The most common metastatic sites
re the lungs (80%) and vagina (30%) [9]. Metastasis to other sites,
uch as liver and brain, are rare without pulmonary metastases.
p to 40% of patients with negative ﬁndings for lung metastases
n a chest radiograph will have metastases diagnosed on a chest
T scan [10]. Pulmonary wedge resection has been shown to be
ffective for treating patients with low-risk GTN who develop
esistant pulmonary nodules after exhausting primary and sec-
ndary chemotherapy. The criteria that predict a favorable outcome
nclude the following [11]: 1) absence of other systemic metastases,
) presence of a unilateral solitary nodule, 3) no uterine involve-
ent, and 4) a serum level of hCG <1500 mIU/mL.
CCA of the lung could represent metastases that arises from
nknown trophoblastic disease, which might undergo a sponta-
eous regression sometimes leaving only the uterus [12,13]. This
henomenon, so-called “burned out” hypothesis, would represent
 unique and speciﬁc feature of choriocarcinoma that is likely to
ecome metastatic before detection of the primary lesion. In the
resent case, despite gynecologic surgery for an ovarian tumor, we
ould not detect the primary site of the lung metastasis. Before a
horacotomy, we considered the possibility of metastasis because
f the history of HM;  however, we could not make a diagnosis of
etastasis from gestational CCA because the interval was relatively
ong (6 years). Tomoda et al. reported that the median interval
etween a preceding molar pregnancy and the diagnosis of chorio-
arcinoma was approximately 36.5 months (range, 5–247 months),
nd the longest reported interval was 20 years and 7 months [14].
he possibility of choriocarcinoma arising as a solitary lung tumor
hould be considered regardless of the interval from the preceding
olar pregnancy. The patient’s medical history and high concen-
ration of -hCG in preoperative residual serum were helpful in
rriving at a diagnosis of metastatic gestational CCA.
. ConclusionWe  presented pulmonary metastasectomy for very unique and
are metastatic choriocarcinoma arising six years after hydatidi-
orm mole.
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